Trials / Unknown
UnknownNCT03270735
A Clinical Study to Evaluate the Efficacy and Safety of Hemocoagulase Injection
A Multi-centre, Randomised, Double Blind, Placebo Controlled Clinical Study to Evaluate the Efficacy and Safety of Snake Venom Thrombin Injection in the Treatment of Moderate to Severe Hemoptysis
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Lee's Pharmaceutical Limited · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-centre, randomised, double blind, placebo controlled clinical study which is designed to evaluate the efficacy and safety of hemocoagulase in the treatment of moderate to severe hemoptysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Snake venom thrombin (Treatment) | Snake venom thrombin |
| DRUG | Placebo | No snake venom thrombin |
Timeline
- Start date
- 2017-06-06
- Primary completion
- 2018-06-01
- Completion
- 2018-12-01
- First posted
- 2017-09-01
- Last updated
- 2017-09-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03270735. Inclusion in this directory is not an endorsement.